RETNLB and breast neoplasm: Artesunate, at varying concentrations, also suppressed the protein expression of HOXA5, WNT, β-catenin, Fizz1, and Arg-1, thereby modulating the WNT-β-catenin signaling pathway and ultimately curbing the proliferation of breast tumor cells.